Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.340 | 0.340 | 0.000 |
Stocks | 99.660 | 99.660 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.560 | 17.782 |
Price to Book | 3.618 | 2.856 |
Price to Sales | 2.322 | 2.026 |
Price to Cash Flow | 15.421 | 11.657 |
Dividend Yield | 1.426 | 2.105 |
5 Years Earnings Growth | 10.739 | 10.947 |
Name | Net % | Category Average |
---|---|---|
Technology | 30.600 | 22.061 |
Financial Services | 15.930 | 15.464 |
Healthcare | 15.660 | 14.310 |
Industrials | 14.840 | 12.104 |
Consumer Cyclical | 8.500 | 10.670 |
Consumer Defensive | 4.620 | 8.416 |
Communication Services | 4.620 | 7.260 |
Basic Materials | 4.150 | 4.379 |
Utilities | 1.090 | 2.559 |
Number of long holdings: 87
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft Corp | - | 6.05 | - | - | |
NVIDIA Corp | - | 5.45 | - | - | |
Apple Inc | - | 3.83 | - | - | |
Amazon.com Inc | - | 3.35 | - | - | |
Alphabet Inc Class A | - | 2.85 | - | - | |
Eli Lilly and Co | - | 2.42 | - | - | |
Linde PLC | IE000S9YS762 | 2.28 | 401.000 | +0.05% | |
Vertex Pharmaceuticals Inc | - | 2.07 | - | - | |
Novo Nordisk B | DK0062498333 | 2.05 | 937.4 | +1.56% | |
UnitedHealth Group Inc | - | 2.04 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Swisscanto CH IPF I Index Equity Fu | 6.46B | 10.60 | 8.37 | 9.76 | ||
Swisscanto CH IPF III Index EquAST | 3.89B | 10.63 | 7.97 | 9.33 | ||
Swisscanto CH IPF I Index Equity CH | 2.38B | 14.70 | 6.38 | 9.88 | ||
CH0315621927 | 1.94B | 9.13 | -6.73 | - | ||
CH0011792451 | 871.32M | -19.58 | 1.16 | 7.27 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review